Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection

Kidney transplantation is the preferred treatment for patients with end-stage kidney disease, because it prolongs survival and improves quality of life. Allograft biopsy is the gold standard for diagnosing allograft rejection. However, it is invasive and reactive, and continuous monitoring is unreal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jeong-Hoon, Chung, Byung Ha, Lee, Sang-Ho, Jung, Hee-Yeon, Choi, Ji-Young, Cho, Jang-Hee, Park, Sun-Hee, Kim, Yong-Lim, Kim, Chan-Duck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082440/
https://www.ncbi.nlm.nih.gov/pubmed/35417937
http://dx.doi.org/10.3904/kjim.2021.518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082440/
https://www.ncbi.nlm.nih.gov/pubmed/35417937
http://dx.doi.org/10.3904/kjim.2021.518

Ejemplares similares